Join us for a discussion with Prof Paolo Ghia, MD, PhD, from Università Vita Salute San Raffaele, Milan (Italy), as he explores how precision medicine is transforming CLL treatment. 

In this episode, discover how precision medicine is used daily in CLL to decide the best management and  treatment for patients. Listen to Prof Ghia explain how CLL management is moving from traditional chemotherapy to targeted therapies based on specific genetic markers, like immunoglobulin mutational status or P53 aberrations, which help guide treatment decisions. 

Explore the array of targeted therapies available for CLL, including BTK inhibitors and BCL-2 inhibitors, and understand how they target critical pathways in CLL pathogenesis. Gain insights from Prof Ghia on the complexities of selecting the right therapy for each patient based on genetic profile, disease risk, and individual preferences. 

 

Through the discussion, recognise the challenges in CLL management, such as relapse scenarios and emerging therapies, and learn the research strategies being explored for potential cures in CLL

 

This is a series of podcasts covering precision medicine across several disorders, more podcasts will be available in the future. Stay tuned! 

Host: Isabel Olivera-Martinez, PhD

Guest: Prof Lucia de Franceschi

This is the eighth episode in a series of podcasts covering precision medicine across various disorders; more podcasts will be available in the future. Stay tuned!

Learn More

Interested in more content related to CLL? We've got you covered. Check out podcasts, clinical cases, courses, and more on EHA Campus.

What did you think of this podcast? Share your opinions with us in this short feedback survey.

Provide Feedback

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.

https://ehaedu.org/Campus

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.

Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

Facebook: https://e-h-a.link/facebook

LinkedIn: https://www.linkedin.com/company/eha/

Email us: [email protected]

Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe